AI assistant
Sending…
HARROW, INC. — Director's Dealing 2008
Nov 25, 2008
31774_dirs_2008-11-25_77b233d6-6d54-492e-8744-310eac73d2c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP)
CIK: 0001360214
Period of Report: 2008-11-21
Reporting Person: SWANN LYNN C (Director)
More from HARROW, INC.
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Regulatory Filings
2026
Feb 2
Director's Dealing
2026
Jan 8